Rx – Precision Therapeutics
Precision therapeutics is enabled by targeted manipulation of synthetic molecules and materials interactions with biological systems. Talented chemists and biologists at Zymeron develop technologies to precisely control the trafficking of chemical compounds and nanoparticles in living systems and their engagement with molecular and cellular targets including membrane proteins, subcellular organelles and tissue markers.
Precision therapeutics technologies include target protein degradation; pathogen agnostic antibacterials, antivirals and antifungals; long lasting drug implants; bone marrow delivery systems; adjuvanted recombinant nanoparticle vaccine platform.
At Zymeron, our talented scientists discover and advance precision medicine technologies to prevent and treat infectious diseases and immunological disorders. Zymeron’s precision Rx technologies enable the action and effect of pharmaceutical agents at specific biomolecular and subcellular targets.
Drug Delivery & Formulation
The Drug Delivery, Reformulation and Repurpose (D2-R2) program uses the 505(b)(2) pathway to develop improved medicines in niche markets where commercial gaps or clinical opportunities exist. Our in-house formulation experts customize the core delivery technologies to satisfy the unmet medical needs. Drug repurposing is another strategy for clinical development of our product candidates either independently or in collaboration with pharma partners to expand our product pipeline.